PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...
Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
Please provide your email address to receive an email when new articles are posted on . Alcon received FDA approval for its AcrySof IQ aspheric IOL with the UltraSert preloaded delivery system for ...
Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...
FORT WORTH, Texas--(BUSINESS WIRE)--May 21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the Centers for Medicare and Medicaid Services (CMS) recognized the AcrySof(R) IQ intraocular lens (IOL) ...
* FDA APPROVAL OF PANOPTIX WAS BASED ON A PIVOTAL STUDY AT 12 INVESTIGATIONAL SITES IN THE U.S Source text for Eikon: Further company coverage: ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...
SAN FRANCISCO-- (BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results